![Laura Barrow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di Laura Barrow
Precedenti posizioni note di Laura Barrow
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21/08/2018 | 28/01/2020 |
SYNERGY PHARMACEUTICALS INC | Direttore operativo | 01/02/2011 | - |
Direttore Tecnico/Scientifico/R&S | 23/03/2011 | 15/05/2012 |
Formazione di Laura Barrow
St. John's University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Synergy Pharmaceuticals LLC
![]() Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
Achillion Pharmaceuticals, Inc.
![]() Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Borsa valori
- Insiders
- Laura Barrow
- Esperienza